UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase 1 study assessing the steady-state concentration of ceftazidime and avibactam in plasma and epithelial lining fluid following two dosing regimens

Journal of antimicrobial chemotherapy, 2015-10, Vol.70 (10), p.2862-2869

2015

Volltextzugriff (PDF)

Comparing probability of target attainment against Staphylococcus aureus for ceftaroline fosamil, vancomycin, daptomycin, linezolid, and ceftriaxone in complicated skin and soft tissue infection using pharmacokinetic/pharmacodynamic models

Diagnostic microbiology and infectious disease, 2021-04, Vol.99 (4), p.115292-115292, Article 115292

2021

Volltextzugriff (PDF)

Selecting the dosage of ceftazidime–avibactam in the perfect storm of nosocomial pneumonia

European journal of clinical pharmacology, 2020-03, Vol.76 (3), p.349-361

2020

Volltextzugriff (PDF)

Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative Infections

Antimicrobial agents and chemotherapy, 2019-08, Vol.63 (8)

2019

Volltextzugriff (PDF)

Antibody responses of SARS-CoV-2 vaccines amongst health care workers in a tertiary care hospital in Tripura, India: A cross-sectional study

Indian journal of community medicine, 2022-10, Vol.47 (4), p.583-586

2022

Volltextzugriff (PDF)

Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria

Paediatric drugs, 2021-09, Vol.23 (5), p.465-484

2021

Volltextzugriff (PDF)

Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by Pseudomonas aeruginosa

mBio, 2024-02, Vol.15 (2), p.e0316523-e0316523

2024

Volltextzugriff (PDF)

Phase I study assessing the safety, tolerability, and pharmacokinetics of avibactam and ceftazidime–avibactam in healthy Japanese volunteers

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015-08, Vol.21 (8), p.551-558

2015

Volltextzugriff (PDF)

30 Determining a potential alternative empirical antibiotic regimen for the treatment of neonatal sepsis in low- and middle-income settings using pre-clinical in vitro techniques

Clinical infection in practice, 2022-09, Vol.15, p.100191, Article 100191

2022

Volltextzugriff (PDF)

Avibactam Pharmacokinetic/Pharmacodynamic Targets

Antimicrobial agents and chemotherapy, 2018-06, Vol.62 (6)

2018

Volltextzugriff (PDF)

Phase 1 Study Assessing the Pharmacokinetic Profile and Safety of Avibactam in Patients With Renal Impairment

Journal of clinical pharmacology, 2017-02, Vol.57 (2), p.211-218

2017

Volltextzugriff (PDF)

Fun or Frustration: Modelling Discontinuance Intention of Social Media Users

International Journal of Electronic Commerce Studies, 2020, Vol.11 (2), p.107-118

2020

Volltextzugriff (PDF)

Reply to Asempa et al., "The Ongoing Challenge with NDM-Harboring Enterobacteriaceae in Murine Infection Models"

Antimicrobial agents and chemotherapy, 2021-01, Vol.65 (2)

2021

Volltextzugriff (PDF)

Update from the European Committee on Antimicrobial Susceptibility Testing (EUCAST)

Journal of clinical microbiology, 2022-03, Vol.60 (3), p.e0027621-e0027621

2022

Volltextzugriff (PDF)

Towards the Future of Bot Detection: A Comprehensive Taxonomical Review and Challenges on Twitter/X

Computer networks (Amsterdam, Netherlands : 1999), 2024-09, p.110808, Article 110808

2024

Volltextzugriff (PDF)

Upregulation of the Maturation-Inducing Steroid Membrane Receptor in Spotted Seatrout Ovaries by Gonadotropin During Oocyte Maturation and Its Physiological Significance

Biology of reproduction, 2001-01, Vol.64 (1), p.21-29

2001

Volltextzugriff (PDF)

Ceftaroline fosamil doses and breakpoints for Staphylococcus aureus in complicated skin and soft tissue infections

Journal of antimicrobial chemotherapy, 2019-02, Vol.74 (2), p.425-431

2019

Volltextzugriff (PDF)

Dose Selection and Validation for Ceftazidime-Avibactam in Adults with Complicated Intra-abdominal Infections, Complicated Urinary Tract Infections, and Nosocomial Pneumonia

Antimicrobial agents and chemotherapy, 2019-04, Vol.63 (4)

2019

Volltextzugriff (PDF)

Considerations in the Selection of Renal Dosage Adjustments for Patients with Serious Infections and Lessons Learned from the Development of Ceftazidime-Avibactam

Antimicrobial agents and chemotherapy, 2020-03, Vol.64 (4)

2020

Volltextzugriff (PDF)

Dose selection for aztreonam-avibactam, including adjustments for renal impairment, for Phase IIa and Phase III evaluation

European journal of clinical pharmacology, 2024-04, Vol.80 (4), p.529-543

2024

Volltextzugriff (PDF)

Pharmacodynamics of Cefepime Combined with the Novel Extended-Spectrum-β-Lactamase (ESBL) Inhibitor Enmetazobactam for Murine Pneumonia Caused by ESBL-Producing Klebsiella pneumoniae

Antimicrobial agents and chemotherapy, 2020-05, Vol.64 (6)

2020

Volltextzugriff (PDF)

Population Pharmacokinetic Modelling of Ceftazidime and Avibactam in the Plasma and Epithelial Lining Fluid of Healthy Volunteers

Drugs in R&D, 2018-09, Vol.18 (3), p.221-230

2018

Volltextzugriff (PDF)

Pharmacodynamics of Meropenem and Tobramycin for Neonatal Meningoencephalitis: Novel Approaches to Facilitate the Development of New Agents to Address the Challenge of Antimicrobial Resistance

Antimicrobial agents and chemotherapy, 2022-04, Vol.66 (4), p.e0218121-e0218121

2022

Volltextzugriff (PDF)

Assessment of the mass balance recovery and metabolite profile of avibactam in humans and in vitro drug-drug interaction potential

Drug metabolism and disposition, 2014-05, Vol.42 (5), p.932-942

2014

Volltextzugriff (PDF)

Randomized, placebo-controlled study to assess the impact on QT/QTc interval of supratherapeutic doses of ceftazidime-avibactam or ceftaroline fosamil-avibactam

Journal of clinical pharmacology, 2014-03, Vol.54 (3), p.331-340

2014

Volltextzugriff (PDF)

1 – 25 von 174

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(131)
Mit Volltextzugriff
(135)

Publikationsform

Sprache

Englisch
(172)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(106)
Life Sciences & Biomedicine
(81)
Humans
(46)
Pharmacology & Pharmacy
(30)
Male
(29)
Microbiology
(28)
Female
(25)
Physical Sciences
(18)
Pediatrics
(17)
Adult
(15)
Infant, Newborn
(15)
Microbial Sensitivity Tests
(15)
Animals
(14)
Infectious Diseases
(14)
Pharmacokinetics
(14)
Chemistry
(13)
Anti-Bacterial Agents - Pharmacokinetics
(11)
Middle Aged
(11)
Pharmacology
(11)
Adolescent
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Phase 1 study assessing the steady-state concentration of ceftazidime and avibactam in plasma and epithelial lining fluid following two dosing regimens

Comparing probability of target attainment against Staphylococcus aureus for ceftaroline fosamil, vancomycin, daptomycin, linezolid, and ceftriaxone in complicated skin and soft tissue infection using pharmacokinetic/pharmacodynamic models

Selecting the dosage of ceftazidime–avibactam in the perfect storm of nosocomial pneumonia

Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative Infections

Antibody responses of SARS-CoV-2 vaccines amongst health care workers in a tertiary care hospital in Tripura, India: A cross-sectional study

Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria

Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by Pseudomonas aeruginosa

Phase I study assessing the safety, tolerability, and pharmacokinetics of avibactam and ceftazidime–avibactam in healthy Japanese volunteers

30 Determining a potential alternative empirical antibiotic regimen for the treatment of neonatal sepsis in low- and middle-income settings using pre-clinical in vitro techniques

Avibactam Pharmacokinetic/Pharmacodynamic Targets

Phase 1 Study Assessing the Pharmacokinetic Profile and Safety of Avibactam in Patients With Renal Impairment

Fun or Frustration: Modelling Discontinuance Intention of Social Media Users

Reply to Asempa et al., "The Ongoing Challenge with NDM-Harboring Enterobacteriaceae in Murine Infection Models"

Update from the European Committee on Antimicrobial Susceptibility Testing (EUCAST)

Towards the Future of Bot Detection: A Comprehensive Taxonomical Review and Challenges on Twitter/X

Upregulation of the Maturation-Inducing Steroid Membrane Receptor in Spotted Seatrout Ovaries by Gonadotropin During Oocyte Maturation and Its Physiological Significance

Ceftaroline fosamil doses and breakpoints for Staphylococcus aureus in complicated skin and soft tissue infections

Dose Selection and Validation for Ceftazidime-Avibactam in Adults with Complicated Intra-abdominal Infections, Complicated Urinary Tract Infections, and Nosocomial Pneumonia

Considerations in the Selection of Renal Dosage Adjustments for Patients with Serious Infections and Lessons Learned from the Development of Ceftazidime-Avibactam

Dose selection for aztreonam-avibactam, including adjustments for renal impairment, for Phase IIa and Phase III evaluation

Pharmacodynamics of Cefepime Combined with the Novel Extended-Spectrum-β-Lactamase (ESBL) Inhibitor Enmetazobactam for Murine Pneumonia Caused by ESBL-Producing Klebsiella pneumoniae

Population Pharmacokinetic Modelling of Ceftazidime and Avibactam in the Plasma and Epithelial Lining Fluid of Healthy Volunteers

Pharmacodynamics of Meropenem and Tobramycin for Neonatal Meningoencephalitis: Novel Approaches to Facilitate the Development of New Agents to Address the Challenge of Antimicrobial Resistance

Assessment of the mass balance recovery and metabolite profile of avibactam in humans and in vitro drug-drug interaction potential

Randomized, placebo-controlled study to assess the impact on QT/QTc interval of supratherapeutic doses of ceftazidime-avibactam or ceftaroline fosamil-avibactam

Suchergebnisse filtern